the vaccine, Dana–Farber Cancer Institute

Vaccines generated using the cells left over after tumour removal surgery could help to keep patients from redeveloping ...
A personalized neoantigen cancer vaccine generated strong immune responses in renal cell carcinoma patients, leading to ...
Clinical trial using the same technology as Covid-19 vaccines is designed to fight colorectal cancer and prevent it from ...
The vaccine acts like a "wanted poster" unmasking cancer cells that are adept at hiding in the body, only to resurface later.
The fusion of mRNA technology with AI has laid the foundation for ushering in a new era of cancer care. However, conducting ...
Researchers evaluated a neoantigen-targeting personalized cancer vaccine in patients with high-risk, fully resected clear ...
In a bid to tackle cervical cancer, one of the leading causes of cancer-related deaths among women, 500 adolescent girls from ...
A phase 1 study of a personalized cancer vaccine demonstrated antitumor immunity in all treated patients with resected renal ...